Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves

An evidence-based triage plan for cellular therapy distribution is critical in the face of emerging constraints on healthcare resources. We evaluated the impact of treatment delays related to COVID-19 on patients scheduled to undergo hematopoietic cell transplantation (HCT) or chimeric antigen recep...

Descripción completa

Detalles Bibliográficos
Autores principales: Nawas, Mariam T., Shah, Gunjan L., Feldman, Darren R., Ruiz, Josel D., Robilotti, Elizabeth V., Aslam, Anoshe A., Dundas, Mary, Kamboj, Mini, Barker, Juliet N., Cho, Christina, Chung, David J., Dahi, Parastoo B., Giralt, Sergio A., Gyurkocza, Boglarka, Lahoud, Oscar B., Landau, Heather J., Lin, Richard J., Mailankody, Sham, Palomba, M. Lia, Papadopoulos, Esperanza B., Politikos, Ioannis, Ponce, Doris M., Sauter, Craig S., Shaffer, Brian C., Scordo, Michael, van den Brink, Marcel R.M., Perales, Miguel-Angel, Tamari, Roni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2021
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952254/
https://www.ncbi.nlm.nih.gov/pubmed/33728417
http://dx.doi.org/10.1016/j.jtct.2021.02.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952254/
https://www.ncbi.nlm.nih.gov/pubmed/33728417
http://dx.doi.org/10.1016/j.jtct.2021.02.011

Ejemplares similares